HighVista Strategies’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-34,954
| Closed | -$4.04M | – | 156 |
|
2023
Q3 | $4.04M | Hold |
34,954
| – | – | 1.87% | 7 |
|
2023
Q2 | $3.6M | Buy |
34,954
+5,954
| +21% | +$612K | 1.64% | 10 |
|
2023
Q1 | $3.17M | Buy |
+29,000
| New | +$3.17M | 2.58% | 8 |
|
2022
Q4 | – | Sell |
-13,055
| Closed | -$808K | – | 138 |
|
2022
Q3 | $808K | Buy |
13,055
+5,636
| +76% | +$349K | 0.46% | 58 |
|
2022
Q2 | $592K | Sell |
7,419
-837
| -10% | -$66.8K | 0.36% | 70 |
|
2022
Q1 | $869K | Sell |
8,256
-3,042
| -27% | -$320K | 0.55% | 50 |
|
2021
Q4 | $1.22M | Hold |
11,298
| – | – | 0.97% | 32 |
|
2021
Q3 | $1.24M | Buy |
11,298
+2,619
| +30% | +$287K | 0.82% | 33 |
|
2021
Q2 | $813K | Buy |
8,679
+91
| +1% | +$8.52K | 0.58% | 43 |
|
2021
Q1 | $790K | Buy |
+8,588
| New | +$790K | 0.59% | 28 |
|